CACNA1C and nasopharyngeal carcinoma: We find that CDK5 activators, p35/p39 have increased expression in NPC disease and inhibition of CDK5 kinase activity with roscovitine abrogates enhancement of both KV2.1 and CaV1.2 clustering in the PM of NPC neurons.